Multiple ways of C/EBPalpha inhibition in myeloid leukaemia

Eur J Cancer. 2008 Jul;44(11):1516-23. doi: 10.1016/j.ejca.2008.04.022.

Abstract

Transcription factors play a crucial role in myeloid differentiation and lineage determination. Tumour suppressor protein C/EBPalpha is a key regulator of granulocytic differentiation whose functional inactivation has become a pathophysiological signature of myeloid leukaemia. In this review we describe various mechanisms such as antagonistic protein-protein interaction, mutation and posttranslational modifications of C/EBPalpha which lead to its transcriptional inhibition and render C/EBPalpha inactive in its functions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • CCAAT-Enhancer-Binding Protein-alpha / antagonists & inhibitors*
  • Forecasting
  • Humans
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / metabolism*
  • Mutation*
  • Promoter Regions, Genetic
  • RNA, Messenger / metabolism

Substances

  • CCAAT-Enhancer-Binding Protein-alpha
  • RNA, Messenger